BIOTECH SCORES BIG THIRD-QUARTER GAINS
BIOTECH SCORES BIG THIRD-QUARTER GAINS
Substantial revenue and earnings growth continued unabated for yet another quarter
DRUG EARNINGS RALLY IN THE THIRD QUARTER
DRUG EARNINGS RALLY IN THE THIRD QUARTER
Major pharmaceutical firms see improvement in sales and earnings as the year progresses
It Lives for 29 Years?
It Lives for 29 Years?
A lawsuit filed April 11 in the U.S. District Court in Los Angeles has grabbed the attention of the life sciences community. The key parties are three high-profile biotech developers: MedImmune, Genentech and Celltech. MedImmune is challenging the validity and enforceability of an important Genentech patent. Behind that patent, MedImmune charges, is an illegal, anti-competitive agreement that ‘profoundly and fundamentally altered the competitive landscape in the biotechnology industry.’
Big pharma plays hard ball with little biotech
Big pharma plays hard ball with little biotech
If you play with the big boys you might get hurt…
USDA Sued Over Drug-Growing Crops
USDA Sued Over Drug-Growing Crops
A coalition of environmental groups and consumer advocates sued the U.S. Agriculture Department in federal court on Wednesday to try to halt the experimental planting of biotech crops engineered to make medicine.
Get updates by email
Editor
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
and Share
Reading
Translator
© Copyright - BiotechBlog — A thinkBiotech product
Recent Comments